Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs RegenCen

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and RegenCen head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 494 · Grade C

RegenCen

Visit RegenCen Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 51 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make RegenCen a bad call — it's best for people seeking regional clinic follow-up who compare the actual medication, bundled services and cancellation terms before choosing a program. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
70
Transparency
90
23
Access Breadth
93
36
Clinical Oversight
92
76
Track Record
88
74
CoreAge RxBrief Score 94 · 51RegenCen

Price, coverage & the tracker

CoreAge RxRegenCen
Brief Score94/100 (A)51/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Current complete quote unconfirmed

Named weight-care programs include different services; exact preparation, medication quantity and full selected payment unconfirmed.

Virtual care advertised in MI and FL. Complimentary consultation does not establish cancellation, renewal or unused-package refunds.

Full price details

Semaglutide weight-care programs offered; exact preparation and complete current quote unknown; eight-week and four-month program descriptions do not establish a full medication-specific price

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current complete quote unconfirmed

Named weight-care programs include different services; exact preparation, medication quantity and full selected payment unconfirmed.

Virtual care advertised in MI and FL. Complimentary consultation does not establish cancellation, renewal or unused-package refunds.

Full price details

Tirzepatide weight-care and maintenance programs offered; exact preparation and complete current quote unknown; no complete public selected-program price established

CoverageUS only; restrictions by state, confirmed at intakeClinics and virtual care advertised in Michigan and Florida; confirm the selected provider, treatment and dispensing access for the patient’s location
Brand-name accessNot confirmedThe reviewed pages do not establish a current named branded GLP-1 prescribing program; confirm the exact prescription.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

RegenCen: Eight-week, four-month and maintenance programs differ. No complete selected price or exact preparation established; Michigan/Florida telehealth and refund terms need individual confirmation.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.